Impact of radiotherapy duration on outcomes in patients with esophageal cancer treated with definitive concurrent radiotherapy and chemotherapy on RTOG trials 8501 and 9405.
Christopher L. Hallemeier(Mayo Clinic in Arizona), Christopher H. Crane(Memorial Sloan Kettering Cancer Center), Ritsuko Komaki(The University of Texas MD Anderson Cancer Center), David A. Bush(Loma Linda University), Jennifer Moughan(NRG Oncology), Elizabeth Gore(Medical College of Wisconsin), Michael G. Haddock(Mayo Clinic in Arizona), Kenneth L. Zeitzer(Jefferson Einstein Philadelphia Hospital), Mitchell D. Schnall(California University of Pennsylvania), Arnold Herskovic(Rush University Medical Center), Bruce D. Minsky(The University of Texas MD Anderson Cancer Center), Pierre Major(Juravinski Cancer Centre), Rojymon Jacob(University of Alabama at Birmingham), Madhur Garg(Albert Einstein College of Medicine), Harold Kim(Western University)
Cited by 0
Related Papers
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
|CA A Cancer Journal for Clinicians|2007|2.6k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
|The Lancet Oncology|2016|1.1k
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
|New England Journal of Medicine|2016|1k